-
Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic.
Biochemistry. 1999 Jul 20;38(29):9405-16
PMID: 10413516
-
Oligomeric modeling and electrostatic analysis of the gp120 envelope glycoprotein of human immunodeficiency virus.
J Virol. 2000 Feb;74(4):1961-72
PMID: 10644369
-
Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection.
Nat Med. 2000 Feb;6(2):200-6
PMID: 10655110
-
Energetics of the HIV gp120-CD4 binding reaction.
Proc Natl Acad Sci U S A. 2000 Aug 1;97(16):9026-31
PMID: 10922058
-
Crystallization and preliminary structure determination of an intact human immunoglobulin, b12: an antibody that broadly neutralizes primary isolates of HIV-1.
Acta Crystallogr D Biol Crystallogr. 2001 Jan;57(Pt 1):168-71
PMID: 11134947
-
Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates.
Structure. 2000 Dec 15;8(12):1329-39
PMID: 11188697
-
Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design.
Science. 2001 Aug 10;293(5532):1155-9
PMID: 11498595
-
Passive immunization with human neutralizing monoclonal antibodies: correlates of protective immunity against HIV.
Vaccine. 2002 May 6;20(15):1956-60
PMID: 11983253
-
Mutagenic stabilization and/or disruption of a CD4-bound state reveals distinct conformations of the human immunodeficiency virus type 1 gp120 envelope glycoprotein.
J Virol. 2002 Oct;76(19):9888-99
PMID: 12208966
-
Fine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type 1 gp120.
J Virol. 2003 Jan;77(1):642-58
PMID: 12477867
-
CD4 binding site antibodies inhibit human immunodeficiency virus gp120 envelope glycoprotein interaction with CCR5.
J Virol. 2003 Jan;77(1):713-8
PMID: 12477875
-
HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites.
Nature. 2002 Dec 12;420(6916):678-82
PMID: 12478295
-
Analysis of the antigen combining site: correlations between length and sequence composition of the hypervariable loops and the nature of the antigen.
J Mol Biol. 2003 Jan 10;325(2):337-54
PMID: 12488099
-
QSYP peptide sequence is selected from phage display libraries by bovine IgG contaminants in monoclonal antibody preparations.
Biotechniques. 2003 Jan;34(1):132-4, 137-41
PMID: 12545550
-
Antibody neutralization and escape by HIV-1.
Nature. 2003 Mar 20;422(6929):307-12
PMID: 12646921
-
Molecular features of the broadly neutralizing immunoglobulin G1 b12 required for recognition of human immunodeficiency virus type 1 gp120.
J Virol. 2003 May;77(10):5863-76
PMID: 12719580
-
A novel human antibody against human immunodeficiency virus type 1 gp120 is V1, V2, and V3 loop dependent and helps delimit the epitope of the broadly neutralizing antibody immunoglobulin G1 b12.
J Virol. 2003 Jun;77(12):6965-78
PMID: 12768015
-
Tyrosine sulfation of human antibodies contributes to recognition of the CCR5 binding region of HIV-1 gp120.
Cell. 2003 Jul 25;114(2):161-70
PMID: 12887918
-
Discontinuous, conserved neutralization epitopes overlapping the CD4-binding region of human immunodeficiency virus type 1 gp120 envelope glycoprotein.
J Virol. 1992 Sep;66(9):5635-41
PMID: 1380099
-
Expressed murine and human CDR-H3 intervals of equal length exhibit distinct repertoires that differ in their amino acid composition and predicted range of structures.
J Mol Biol. 2003 Dec 5;334(4):733-49
PMID: 14636599
-
Crystal structure of an intact human IgG: antibody asymmetry, flexibility, and a guide for HIV-1 vaccine design.
Adv Exp Med Biol. 2003;535:55-66
PMID: 14714888
-
Crystal structure of the broadly cross-reactive HIV-1-neutralizing Fab X5 and fine mapping of its epitope.
Biochemistry. 2004 Feb 17;43(6):1410-7
PMID: 14769016
-
Structural rationale for the broad neutralization of HIV-1 by human monoclonal antibody 447-52D.
Structure. 2004 Feb;12(2):193-204
PMID: 14962380
-
Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120.
Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):2706-11
PMID: 14981267
-
HIV vaccine design and the neutralizing antibody problem.
Nat Immunol. 2004 Mar;5(3):233-6
PMID: 14985706
-
The long third complementarity-determining region of the heavy chain is important in the activity of the broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2F5.
J Virol. 2004 Mar;78(6):3155-61
PMID: 14990736
-
Synthetic antibodies from a four-amino-acid code: a dominant role for tyrosine in antigen recognition.
Proc Natl Acad Sci U S A. 2004 Aug 24;101(34):12467-72
PMID: 15306681
-
Characterization of molecular features, antigen-binding, and in vitro properties of IgG and IgM variants of 4E10, an anti-HIV type 1 neutralizing monoclonal antibody.
AIDS Res Hum Retroviruses. 2004 Jul;20(7):755-62
PMID: 15307922
-
Improved design of an antigen with enhanced specificity for the broadly HIV-neutralizing antibody b12.
Protein Eng Des Sel. 2004 Oct;17(10):749-58
PMID: 15542540
-
Structure of an unliganded simian immunodeficiency virus gp120 core.
Nature. 2005 Feb 24;433(7028):834-41
PMID: 15729334
-
On the nature of antibody combining sites: unusual structural features that may confer on these sites an enhanced capacity for binding ligands.
Proteins. 1990;7(2):112-24
PMID: 1691497
-
Conformational epitope on gp120 important in CD4 binding and human immunodeficiency virus type 1 neutralization identified by a human monoclonal antibody.
J Virol. 1991 Jan;65(1):489-93
PMID: 1702163
-
An IgG human monoclonal antibody that reacts with HIV-1/GP120, inhibits virus binding to cells, and neutralizes infection.
J Immunol. 1991 Jun 15;146(12):4325-32
PMID: 1710248
-
Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding.
J Exp Med. 1991 Aug 1;174(2):407-15
PMID: 1713252
-
Characterization of a discontinuous human immunodeficiency virus type 1 gp120 epitope recognized by a broadly reactive neutralizing human monoclonal antibody.
J Virol. 1991 Nov;65(11):6188-93
PMID: 1717717
-
[Model phases: probabilities and bias.
Methods Enzymol. 1997;277:110-28
PMID: 18488308
-
Structure, function and properties of antibody binding sites.
J Mol Biol. 1991 Jan 5;217(1):133-51
PMID: 1988675
-
Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120.
Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2189-93
PMID: 2006155
-
Improved methods for building protein models in electron density maps and the location of errors in these models.
Acta Crystallogr A. 1991 Mar 1;47 ( Pt 2):110-9
PMID: 2025413
-
Dissociation of gp120 from HIV-1 virions induced by soluble CD4.
Science. 1990 Nov 23;250(4984):1139-42
PMID: 2251501
-
[20] Processing of X-ray diffraction data collected in oscillation mode.
Methods Enzymol. 1997;276:307-326
PMID: 27799103
-
Measurement of protein using bicinchoninic acid.
Anal Biochem. 1985 Oct;150(1):76-85
PMID: 3843705
-
Unusual distributions of amino acids in complementarity-determining (hypervariable) segments of heavy and light chains of immunoglobulins and their possible roles in specificity of antibody-combining sites.
J Biol Chem. 1977 Oct 10;252(19):6609-16
PMID: 408353
-
Exploration of antigenic variation in gp120 from clades A through F of human immunodeficiency virus type 1 by using monoclonal antibodies.
J Virol. 1994 Dec;68(12):8350-64
PMID: 7525988
-
Neutralizing recombinant human antibodies to a conformational V2- and CD4-binding site-sensitive epitope of HIV-1 gp120 isolated by using an epitope-masking procedure.
J Immunol. 1995 Jan 15;154(2):893-906
PMID: 7529290
-
Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding.
J Virol. 1995 Sep;69(9):5723-33
PMID: 7543586
-
Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding.
J Virol. 1993 Jul;67(7):3978-88
PMID: 7685405
-
Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates.
J Virol. 1995 Jul;69(7):4413-22
PMID: 7769703
-
Analysis of antigenic surfaces of proteins.
FASEB J. 1995 Jan;9(1):87-93
PMID: 7821764
-
X-ray structures of fragments from binding and nonbinding versions of a humanized anti-CD18 antibody: structural indications of the key role of VH residues 59 to 65.
Proteins. 1994 Jan;18(1):49-62
PMID: 7908437
-
Structural characterization of broadly neutralizing human monoclonal antibodies against the CD4 binding site of HIV-1 gp120.
Mol Immunol. 1994 Oct;31(15):1149-60
PMID: 7935503
-
Anatomy of the antibody molecule.
Mol Immunol. 1994 Feb;31(3):169-217
PMID: 8114766
-
Variable region genes of anti-HIV human monoclonal antibodies: non-restricted use of the V gene repertoire and extensive somatic mutation.
Mol Immunol. 1993 Nov;30(16):1543-51
PMID: 8232339
-
Functional and immunologic characterization of human immunodeficiency virus type 1 envelope glycoproteins containing deletions of the major variable regions.
J Virol. 1993 Aug;67(8):4557-65
PMID: 8331723
-
Neutralization of HIV-1 by F105, a human monoclonal antibody to the CD4 binding site of gp120.
J Acquir Immune Defic Syndr. 1993 Jan;6(1):7-14
PMID: 8417177
-
Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1.
J Virol. 1996 Feb;70(2):1100-8
PMID: 8551569
-
Interactions of protein antigens with antibodies.
Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):7-12
PMID: 8552677
-
Human immunodeficiency virus type 1 membrane fusion mediated by a laboratory-adapted strain and a primary isolate analyzed by resonance energy transfer.
J Virol. 1996 Sep;70(9):6437-41
PMID: 8709277
-
Accessing the Kabat antibody sequence database by computer.
Proteins. 1996 May;25(1):130-3
PMID: 8727325
-
Antibody-antigen interactions: contact analysis and binding site topography.
J Mol Biol. 1996 Oct 11;262(5):732-45
PMID: 8876650
-
CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5.
Nature. 1996 Nov 14;384(6605):179-83
PMID: 8906795
-
Evaluation of monoclonal antibodies to human immunodeficiency virus type 1 primary isolates by neutralization assays: performance criteria for selecting candidate antibodies for clinical trials. AIDS Clinical Trials Group Antibody Selection Working Group.
J Infect Dis. 1997 May;175(5):1056-62
PMID: 9129066
-
Replication and neutralization of human immunodeficiency virus type 1 lacking the V1 and V2 variable loops of the gp120 envelope glycoprotein.
J Virol. 1997 Dec;71(12):9808-12
PMID: 9371651
-
Synergistic neutralization of simian-human immunodeficiency virus SHIV-vpu+ by triple and quadruple combinations of human monoclonal antibodies and high-titer anti-human immunodeficiency virus type 1 immunoglobulins.
J Virol. 1998 Apr;72(4):3235-40
PMID: 9525650
-
Neutralization of human immunodeficiency virus type 1 by antibody to gp120 is determined primarily by occupancy of sites on the virion irrespective of epitope specificity.
J Virol. 1998 May;72(5):3512-9
PMID: 9557629
-
The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens.
Science. 1998 Jun 19;280(5371):1884-8
PMID: 9632381
-
Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody.
Nature. 1998 Jun 18;393(6686):648-59
PMID: 9641677
-
The antigenic structure of the HIV gp120 envelope glycoprotein.
Nature. 1998 Jun 18;393(6686):705-11
PMID: 9641684
-
Functional and molecular characterization of human monoclonal antibody reactive with the immunodominant region of HIV type 1 glycoprotein 41.
AIDS Res Hum Retroviruses. 1998 Sep 20;14(14):1271-80
PMID: 9764911
-
The atomic structure of protein-protein recognition sites.
J Mol Biol. 1999 Feb 5;285(5):2177-98
PMID: 9925793
-
Probability analysis of variational crystallization and its application to gp120, the exterior envelope glycoprotein of type 1 human immunodeficiency virus (HIV-1).
J Biol Chem. 1999 Feb 12;274(7):4115-23
PMID: 9933605